Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shachar Cohen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Communications Medicine|December 20, 2024
Clinical utility of receptor status prediction in breast cancer and misdiagnosis identification using deep learning on hematoxylin and eosin-stained slidesGil Shamai, Ran Schley, Alexandra Cretu, et al.
NPJ Breast Cancer|May 11, 2026
Prediction of OncotypeDX recurrence score using hematoxylin and eosin-stained whole slide imagesShachar Cohen, Gil Shamai, Edmond Sabo, et al.
The Lancet. Oncology|March 14, 2026
Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation studyGil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy BenefitGil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Communications Medicine|December 20, 2024
Clinical utility of receptor status prediction in breast cancer and misdiagnosis identification using deep learning on hematoxylin and eosin-stained slidesGil Shamai, Ran Schley, Alexandra Cretu, et al.
NPJ Breast Cancer|May 11, 2026
Prediction of OncotypeDX recurrence score using hematoxylin and eosin-stained whole slide imagesShachar Cohen, Gil Shamai, Edmond Sabo, et al.
The Lancet. Oncology|March 14, 2026
Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation studyGil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy BenefitGil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
Pageof 1